Literature DB >> 6155934

Rubella maculopathy.

D H Orth, G A Fishman, M Segall, A Bhatt, Y Yassur.   

Abstract

Three patients with known history of congenital rubella and sudden decrease of vision are presented. Two of the 3 patients had previous eye examinations which showed typical rubella (salt and pepper) retinopathy. All 3 showed macular lesions associated with presumed subretinal neovascularisation.

Entities:  

Mesh：

Year:  1980        PMID： 6155934      PMCID： PMC1039387          DOI： 10.1136/bjo.64.3.201

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  3 in total

1.  The ocular manifestations of congenital rubella.

Authors:  S M Wolff
Journal:  Trans Am Ophthalmol Soc       Date:  1972

2.  Twenty-five-year follow-up of ocular defects in congenital rubella.

Authors:  R Hertzberg
Journal:  Am J Ophthalmol       Date:  1968-08       Impact factor: 5.258

3.  Rubella retinopathy and subretinal neovascularization.

Authors:  A F Deutman; W S Grizzard
Journal:  Am J Ophthalmol       Date:  1978-01       Impact factor: 5.258
  3 in total
  4 in total

1.  Idiopathic sub-retinal neovascular membranes in the macula (hemorrhagic macular choroidopathy of young adults). Clinical report and effectiveness of laser treatment.

Authors:  F G Bottoni; A F Deutman
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

Review 2.  Viral posterior uveitis.

Authors:  Joanne H Lee; Aniruddha Agarwal; Padmamalini Mahendradas; Cecilia S Lee; Vishali Gupta; Carlos E Pavesio; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

3.  Birdshot retinochoroidopathy and subretinal new vessels.

Authors:  G Soubrane; G Coscas; M Binaghi; P Amalric; J A Bernard
Journal:  Br J Ophthalmol       Date:  1983-07       Impact factor: 4.638

4.  Rubella retinopathy with choroidal neovascular membrane in a 7-year-old.

Authors:  Lubhavni Dewan; Nasiq Hasan; Neelima Aron; Rohan Chawla; Dheepak Sundar
Journal:  Indian J Ophthalmol       Date:  2020-06       Impact factor: 1.848
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.